TICKERNERD
Menu
TNONTNONHealthcare · Medical Devices

TNON Stock Forecast: TENON Medical, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$5.93

The 2 Wall Street analysts covering TENON Medical, Inc. hold a median 12-month price target of $44 — +648.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 56 of 100 as at 12 Sept 2026 — in the upper half.

Market cap
$4.0M
Ticker Nerd rank
56 / 100
Median analyst target
$44
Analysts covering
2
Revenue$1.3M+126.8% y/y
Operating income−$3.4M
Net income−$4.0M
Free cash flow−$2.9M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Ticker Nerd rank

TNON stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores TENON Medical, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026
56 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
95
Revisions
87
Growth
81
Volatility
62
Accruals
60
Quality
45
Momentum
30
Value
12
Issuance
3

Size (95): Smaller than most of the companies we track.

Issuance (3): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

TNON stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on TNON, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

What Wall Street says2 analysts
2 Buy0 Hold0 Sell
Low $10Median $44High $79

The green dot is the last close — the median target sits +648.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
9 Apr 2025Alliance Global PartnersInitiatesBuy$3.00
15 Nov 2024Maxim GroupMaintainsBuy—
14 Aug 2024BenchmarkReiteratesSpeculative Buy—
15 Apr 2024BenchmarkMaintainsSpeculative Buy—
10 Mar 2023BenchmarkReiteratesBuy$6.00
6 Sept 2022BenchmarkInitiatesSpeculative Buy—
21 June 2022BenchmarkInitiatesSpeculative Buy$6.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. TNON appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

TNON analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
0
Fundamentals

TENON Medical, Inc. (TNON) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
0.1×

Cheaper than 73% of US stocks

Price / sales
0.7×

Cheaper than 75% of US stocks

Price / book
−1.1×

Cheaper than 94% of US stocks

EV / EBITDA
−0.9×

Cheaper than 67% of US stocks

Growth & margins
Revenue growth (YoY)
126.8%

Higher than 94% of US stocks

Earnings growth (YoY)
126.8%

Higher than 86% of US stocks

Gross margin
63.6%

Higher than 77% of US stocks

Operating margin
−262.2%

Higher than 10% of US stocks

Net margin
−257.9%

Higher than 1% of US stocks

Returns & dividend
Return on equity
−551.2%

Higher than 3% of US stocks

Return on assets
−72.0%

Higher than 5% of US stocks

Dividend yield
12.1%

Higher than 92% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

TENON Medical, Inc. (TNON) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • TENON Medical, Inc. has a market value of $4.0M and an enterprise value of $11.0M.

  • Revenue in the twelve months to 30 June 2026: $5.3M. The latest quarter grew 126.8% year on year.

  • Net income over the same four quarters: −$13.7M, a −257.9% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$12.1M.

  • Shares outstanding: 496,456.

  • Trailing P/E: 0.1×; forward P/E: −0.5× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 12.10%, paying out 0% of earnings.

  • TENON Medical, Inc. employs 26 people — $204K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Sept 2026

Data provided by Twelve Data

Peers

TNON vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
TNONTENON Medical, Inc.$4.0M
56
INBSIntelligent Bio Solutions, Inc.$6.4M
11
VNRXVolitionRX Ltd.$5.8M
38
AIDX20/20 Biolabs, Inc.$6.9M
3
ITOCiTonic Holdings Ltd.$5.2M
25
NVNOenVVeno Medical Corp.$7.3M
32
ICCMIceCure Medical Ltd.$7.6M
38

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own TENON Medical, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest TNON news & analysis

WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338

PRNewsWire · 11 Sept 2026positive

WallachBeth Capital announced that Tenon Medical entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants for 572,179 shares of common stock, generating gross proceeds of approximately $2,872,338.

Why it matters — This warrant exercise brings fresh capital of roughly $2.9 million to Tenon Medical, providing additional funding for the company.

Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338

Accesswire · 11 Sept 2026neutral

Tenon Medical announced warrant exercise agreements with an institutional investor to immediately exercise outstanding warrants for aggregate gross proceeds of approximately $2,872,338. In consideration, the holders will receive new unregistered warrants in a private placement to purchase up to 858,269 shares of common stock at an exercise price of $5.02 per share.

Why it matters — TNON watchers would care because the company secured roughly $2.87 million in gross cash proceeds while issuing additional warrants that represent potential future dilution of common stock.

Tenon Medical Stock Extends Multi-Day Rally: What's Happening?

Benzinga · 11 Sept 2026positive

Tenon Medical shares traded sharply higher Friday morning, extending a multi-day rally that followed a major balance sheet restructuring. The stock has continued to climb after the restructuring announcement.

Why it matters — TNON watchers would care because the sustained rally reflects market response to the company's balance sheet restructuring.

Tenon Medical Stock Surges Thursday: What's Driving the Action?

Benzinga · 10 Sept 2026positive

Tenon Medical announced the full early repayment of its outstanding senior convertible notes, eliminating a major dilutive overhang for shareholders. The news drove the company's shares higher on Thursday morning.

Why it matters — TNON watchers would care because removing the convertible notes reduces potential future dilution for existing shareholders.

Tenon Medical Announces Early Repayment of Its Convertible Notes

Accesswire · 9 Sept 2026positive

Tenon Medical announced it repaid in full its outstanding original issue discount senior convertible promissory notes, which had an aggregate principal balance of approximately $5.16 million, ahead of their September 11, 2026 maturity date. The notes were originally issued on March 11, 2026.

Why it matters — TNON watchers would care because the early repayment is a proactive step to strengthen the company's balance sheet and maintain flexibility to execute on its business momentum.

FAQ

Frequently asked questions about TNON stock

What is the TNON stock price forecast for 2026-2027?

The 2 Wall Street analysts covering TENON Medical, Inc. have a median 12-month price target of $44, with estimates ranging from $10 to $79. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is TNON stock a buy right now?

Of the 2 analysts covering TENON Medical, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks TENON Medical, Inc. 56 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank TNON?

As at 12 Sept 2026, TENON Medical, Inc. ranks 56 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (95 of 100).

Will TNON stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +648.3% from the last close, and Ticker Nerd's factor model ranks TENON Medical, Inc. 56 out of 100 as at 12 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the TNON stock forecast for 2030?

No analyst covering TENON Medical, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for TNON are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $79 over the next 12 months.

What does TENON Medical, Inc. do?

Tenon Medical, Inc. is a medical device company focused on minimally invasive solutions for sacroiliac joint disorders and severe lower back pain.

What is the latest news on TNON?

The most recent item we track (PRNewsWire, 11 Sept 2026): "WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338". WallachBeth Capital announced that Tenon Medical entered into warrant exercise agreements with an institutional investor to exercise outstanding warrants for 572,179 shares of common stock, generating gross proceeds of approximately $2,872,338.

Company

About TENON Medical, Inc.

Tenon Medical, Inc. is a medical device company focused on minimally invasive solutions for sacroiliac joint disorders and severe lower back pain. Tenon Medical develops and commercializes the Catamaran SI Joint Fusion System, along with related fixation technology, designed to stabilize and fuse the sacroiliac joint through an inferior-posterior approach using a titanium implant. Its products are used in primary SI joint procedures, revision procedures involving failed implants, and adjunct applications alongside spine fusion constructs. Based in Los Gatos, California, Tenon Medical serves the surgical spine and orthopedics market with implant systems aimed at addressing SI joint dysfunction and sacro-pelvic instability.

CEO Mr. Steven M. Foster · 26 employees · United States · https://www.tenonmed.com